For someone exploring GLP-1 treatment in Thailand, three questions are more useful than a generic price list: Is the exact medicine registered for the relevant use? Who provides medical assessment? What will the complete course of care cost?
Local-language quick guide
สรุปภาษาไทย: ก่อนรับบริการด้าน GLP-1 ในประเทศไทย ควรตรวจสอบทะเบียนยากับสำนักงานคณะกรรมการอาหารและยา (อย.) และสอบถามคลินิกเกี่ยวกับแพทย์ผู้ดูแล ค่าใช้จ่ายทั้งหมด และการติดตามผล ข้อมูลในหน้านี้ไม่ได้ยืนยันว่ายาหรือบริการใดได้รับอนุญาตในปัจจุบัน
The detailed guide below is currently in English. Other language editions require editorial review before publication.
Where to verify a GLP-1 medicine in Thailand
Search by English or Thai trade name, active ingredient or registration number. Thai FDA describes its drug search as preliminary reference information, so resolve uncertain matches with the agency or a licensed pharmacist.
Open the official Thai Food and Drug Administration (Thai FDA) resource and keep the product name and registration details with the date checked. Search results can change, and a registration for one brand, indication or presentation should not be extended to another.
GLP-1 medicines are not a single interchangeable group. Semaglutide and tirzepatide have different receptor actions and can have different labels or permitted indications across markets. The WHO’s 2025 guideline discusses these therapies for adults with obesity as part of broader care, rather than a substitute for medical assessment.
Finding weight-management clinics
Our Thailand clinic directory links to documented provider websites rather than asserting that every listed clinic offers a particular prescription. Bangkok Hospital, Siriraj Obesity and Metabolic Center and Bangkok Hospital Phuket appear in the source-linked directory; their GLP-1 prescribing services and current charges require direct confirmation.
A useful first contact should establish clinician qualifications, referral requirements, relevant examinations, ongoing reviews, the exact prescribing and dispensing pathway, and how to handle adverse effects or treatment changes.
Understanding GLP-1 costs in THB
Thailand clinic enquiries often combine a consultation, body-composition measurement, laboratory investigations and follow-up visits. An advertised hospital screening package is not the same thing as a monthly medicine price.
Ask whether the quoted amount includes clinician assessment, laboratory work, medicine if clinically indicated, injection training and follow-up. Request a breakdown in Thai baht.
Use the GLP1Asia treatment cost calculator with quoted fees. It calculates a scenario from your entries; it is not a price database. You can also read how to compare treatment costs.
Which GLP-1 medicines should I compare?
Start with two research summaries: semaglutide in Asia and tirzepatide in Asia. They explain the medicine classes, common consultation questions and why brand registration must be checked country by country. The treatment comparison covers additional agents and research-stage compounds.
Frequently asked questions about GLP-1 in Thailand
How do I verify a GLP-1 medicine in Thailand?
Check the official register published by Thai Food and Drug Administration (Thai FDA), using the exact brand, active ingredient or registration number. A generic website mention is not proof of a specific current registration.
How much does GLP-1 care cost in Thailand?
It depends on the provider and what is included. Ask for itemised consultation, diagnostics, follow-up and any medicine cost in THB; a screening package is not a medicine price.
Can I find GLP-1 clinics in Thailand?
GLP1Asia lists source-linked obesity or weight-management service references. Confirm with each provider whether a qualified clinician currently offers GLP-1 evaluation and which medicines, if any, are available.
Are semaglutide and tirzepatide the same?
No. Semaglutide acts at the GLP-1 receptor; tirzepatide acts at GIP and GLP-1 receptors. Indications, products, clinical decisions and country-specific registration are not interchangeable.
Does a clinic listing mean GLP1Asia has verified a doctor or product?
No. Listing links show a source for an organisation or service; they are not an independent licence audit or proof of prescribing availability.
How often is information about Thailand checked?
Automated checks may detect website changes, with regulatory sources checked when due and some directory and price sources scheduled weekly. A successful fetch is not proof that clinical information or current product status has been verified.
Primary sources and next checks
- Thai Food and Drug Administration (Thai FDA) — official medicine or regulator information
- World Health Organization — 2025 GLP-1 obesity guideline
- MedlinePlus — semaglutide medicine information
- MedlinePlus — tirzepatide medicine information